Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tff Pharmaceuticals Inc
TFFPCurrent price
2.31 USD
-0.03 USD (-1.28%)
Last closed
2.36 USD
Company
www.tffpharma.com
ISIN
US87241J1043
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
7 659 948 USD
Yield for 12 month
-72.50 %
1Y
3Y
5Y
10Y
15Y
TFFP
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Fort Worth, Texas. Address: 1751 River Run, Fort Worth, TX, United States, 76107
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30 USDP/E ratio
–Dividend Yield
–Current Year
+733 871 USD
Last Year
–
Current Quarter
+650 222 USD
Last Quarter
+203 273 USD
Current Year
+231 391 USD
Last Year
-388 221 USD
Current Quarter
+509 630 USD
Last Quarter
+63 090 USD
Key Figures TFFP
1 year
3 years
5 years
10 years
EBITDA
-19 006 206 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-105.91 %
PEG Ratio
–
Return On Equity TTM
-213.51 %
Wall Street Target Price
30 USD
Revenue TTM
1 202 586 USD
Book Value
1.81 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
95.1 %
Dividend Yield
–
Gross Profit TTM
-21 212 704 USD
Earnings per share
-6.88 USD
Diluted Eps TTM
-6.88 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TFFP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TFFP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
19.12.2023
Dividend Date
–
Stock Valuation TFFP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
7.1405
Price Sales TTM
6.3696
Enterprise Value EBITDA
-0.5036
Price Book MRQ
1.3033
Financials TFFP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TFFP
For 52 weeks
1.35 USD
11 USD
50 Day MA
1.94 USD
Shares Short Prior Month
144 328
200 Day MA
4.27 USD
Short Ratio
2.69
Shares Short
140 271
Short Percent
4.1 %
BeatStart